Drug Type Fab fragment |
Synonyms- |
Target |
Mechanism CD300A inhibitors(CD300a molecule inhibitors), IgE inhibitors(Immunoglobulin E inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | IL | - |